SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 240 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,758 | -47.0% | 3,437 | -42.2% | 0.02% | -61.5% |
| Q2 2023 | $178,797 | -16.7% | 5,948 | +0.4% | 0.05% | -24.6% |
| Q1 2023 | $214,699 | -4.8% | 5,926 | -6.2% | 0.07% | -8.0% |
| Q4 2022 | $225,470 | +77.5% | 6,321 | +68.5% | 0.08% | +19.0% |
| Q3 2022 | $127,000 | -17.5% | 3,752 | -29.6% | 0.06% | -33.7% |
| Q2 2022 | $154,000 | +40.0% | 5,327 | +56.9% | 0.10% | +72.7% |
| Q1 2022 | $110,000 | +77.4% | 3,396 | +59.1% | 0.06% | +89.7% |
| Q4 2021 | $62,000 | +5.1% | 2,135 | -2.9% | 0.03% | -23.7% |
| Q3 2021 | $59,000 | +5.4% | 2,198 | +20.0% | 0.04% | +8.6% |
| Q2 2021 | $56,000 | – | 1,832 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |